Le Bonheur Children's Hospital

Open enrollment with a later-stage pipeline tilt

According to ClinicalTrials.gov-derived indexes, Le Bonheur Children's Hospital sits in the top decile of US sponsors by registered trial count (#987 of 15,742 sponsors by registered trial count).

14 total trials 2 currently recruiting 8 completed later-stage tilt top decile by trial count

Le Bonheur Children's Hospital: 14 sponsored US clinical trials, 2 recruiting.

Le Bonheur Children's Hospital sponsors 14 registered US clinical trials on ClinicalTrials.gov, 2 of them currently recruiting, and 8 completed. 4 of these trials are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Feeding Intolerance, with 1 trials.

Top-decile sponsor footprint

Le Bonheur Children's Hospital ranks in the top decile of sponsors by registered trial count (#987 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.

Trial completion reliability score

F 21/100

8 of 11 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (72.7%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.

Open and recent trials

14 total, page 1 of 1

RECRUITING

PRecision Integrated Saturation Monitor

NCT07686341
RECRUITING NA

Gastric Feeding Versus Transpyloric Feeding in Infants with Severe Bronchopulmonary Dysplasia, a Crossover Study

NCT06821776
TERMINATED Phase 4

NSAIDs vs Opioids for Post-op Pain in Supracondylar Humerus Fractures

NCT04905563
NOT YET RECRUITING

The U.S. PDA Registry

NCT04205877
TERMINATED NA

Association of Insulin Resistance and FGF21 on Cardiac Function in Pediatric Dilated Cardiomyopathy

NCT04222101
COMPLETED NA

Video-Assisted Counseling for HPV Vaccination

NCT03510091
COMPLETED NA

Sham Feeding Post-operative Infants

NCT03350022
TERMINATED

HD5 Levels in Catheter Versus Bag Urine Specimens in Young Children for the Diagnosis of UTI

NCT03163394
COMPLETED Phase 1

Tuberous Sclerosis Complex: Facial Angiofibroma Skin Cream

NCT01853423
COMPLETED Phase 4

7% Hypertonic Saline for Acute Bronchiolitis

NCT01871857
COMPLETED

Pediatric Seizure Movement Bed Alarm

NCT01855178
COMPLETED Phase 3

IV Lacosamide: The Safety of Intravenous Lacosamide

NCT01981447
COMPLETED Phase 4

The Safety of Intravenous Lacosamide

NCT00832884
COMPLETED

Biomarker of Children With Familial Autoimmune History

NCT01541033

Phase Distribution

PhaseTrial count
Phase 1 1
Phase 3 1
Phase 4 3

Therapeutic Areas

Feeding Intolerance 1
Human Papillomavirus Infection 1
Bronchopulmonary Dysplasia 1
Epilepsy 1

Where Le Bonheur Children's Hospital enrollment is open (later-stage tilt)

2 recruiting of 14 indexed (14% open); 8 completed (57%).

Phase mix: 4 late (III/IV) vs 1 early (I/II) (later-stage heavy).

Top condition: Feeding Intolerance (1 trial), 3 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

Le Bonheur Children's Hospital: open-pipeline peers nationwide

Peers matched on 14 registered trials and 14% open enrollment, not the therapeutic-area sidebar.

Le Bonheur Children's Hospital sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 01020304050 0%5%10%15%20% Total trials Recruiting share Le Bonheur Children's Hospital3-C Institute for Social DevelopmentAbbott Medical OpticsAbbott RDx CardiometabolicAcceleron Pharma, Inc., a wholly-owned subsidiary of Merck & Co., Inc., Rahway, NJ USAAcademic and Community Cancer Research UnitedAdaptive BiotechnologiesAgelessRxAlaska Blind Child Discovery
Le Bonheur Children's Hospital sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

Le Bonheur Children's Hospital sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 14 trials (± recruiting share)

Sponsors near 14% open enrollment (± trial volume)

Related

Read our methodology - how this data is sourced, computed, and verified.

What to do with this Le Bonheur Children's Hospital page

14 registered trials is a research-attention snapshot, not an endorsement of Le Bonheur Children's Hospital or any single study.

  • 2 of Le Bonheur Children's Hospital's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
  • Feeding Intolerance is the condition Le Bonheur Children's Hospital studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Feeding Intolerance trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Le Bonheur Children's Hospital pipeline card: 14 registered trials from official public datasets.Report a data error.